| Original language | English |
|---|---|
| Pages (from-to) | 432-435 |
| Number of pages | 4 |
| Journal | Chest |
| Volume | 160 |
| Issue number | 2 |
| Early online date | 27 Mar 2021 |
| DOIs |
|
| Publication status | Published - Aug 2021 |
Funding
FUNDING/SUPPORT: The TASMA study is funded by the Dutch Lung Foundation [Grant 5.2.13.064JO ], the Netherlands Organization for Health Research and Development (ZonMw) [Grant 90713477 ], the Dutch Foundation ‘Asthma Bestrijding’ [Grant SAB 2018/041], and Boston Scientific. This work is part of the MedPhot research program 00770372 with project number 00770384, which is (partly) financed by the Dutch Research Council (NWO). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement [Grant 871124 ]. FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: J. T. A. reports grants from Boston Scientific , ZonMw , and the Dutch Lung Foundation , during the conduct of the study; and non-financial support from Boston Scientific. J. F. B. reports research grants from NWO (Dutch Science Foundation) and Heidelberg Engineering, during the conduct of the study; and royalties from intellectual property on core OCT technology owned and managed by his former employer, Massachusetts General Hospital Corp. P. I. B. reports grants from Boston Scientific, ZonMw, and the Dutch Lung Foundation, during the conduct of the study; and non-financial support from Boston Scientific, related to an investigator-initiated research grant. None declared (M. V., P. C. W., J. W., A. W. M. G., F. F., J. N. S. H.). FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: J. T. A. reports grants from Boston Scientific, ZonMw, and the Dutch Lung Foundation, during the conduct of the study; and non-financial support from Boston Scientific. J. F. B. reports research grants from NWO (Dutch Science Foundation) and Heidelberg Engineering, during the conduct of the study; and royalties from intellectual property on core OCT technology owned and managed by his former employer, Massachusetts General Hospital Corp. P. I. B. reports grants from Boston Scientific, ZonMw, and the Dutch Lung Foundation, during the conduct of the study; and non-financial support from Boston Scientific, related to an investigator-initiated research grant. None declared (M. V., P. C. W., J. W., A. W. M. G., F. F., J. N. S. H.).FUNDING/SUPPORT: The TASMA study is funded by the Dutch Lung Foundation [Grant 5.2.13.064JO], the Netherlands Organization for Health Research and Development (ZonMw) [Grant 90713477], the Dutch Foundation ‘Asthma Bestrijding’ [Grant SAB 2018/041], and Boston Scientific. This work is part of the MedPhot research program 00770372 with project number 00770384, which is (partly) financed by the Dutch Research Council (NWO). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement [Grant 871124].
| Funders | Funder number |
|---|---|
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | |
| Lung Foundation Netherlands | |
| Heidelberg Engineering | |
| Horizon 2020 | |
| Massachusetts General Hospital | 5.2.13.064JO |
| Dutch Foundation ‘Asthma Bestrijding | SAB 2018/041 |
| Horizon 2020 Framework Programme | 871124 |
| Boston Scientific Corporation | 00770384, 00770372 |
| ZonMw | 90713477 |